Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VALIANT Pilot: Valacyclovir for inflammation in HIV/HSV-2 co-infection
NCT01176409Phase 3Completed
- Sponsor
- University Health Network
- Start
- Sep 2010
- Primary completion
- Aug 2013
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of valaciclovir in systemic inflammation, Herpes Simplex Virus Type 2 Infection (HSV-2), sponsored by University Health Network. Started Sep 2010; status: completed.
02
Drugs
valaciclovir
03
Conditions
systemic inflammationHerpes Simplex Virus Type 2 Infection (HSV-2)
Beyond the preview
Go deeper on NCT01176409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01176409.